You are here

P&T News

June 22

Aides and lobbyists get first peek at discussion draft
Charges could be as high as $2,000 for those who did not meet PQRS requirements
Original House bill gets “thumbs down”—critics brace for Senate version
Immune response is noninferior to that of Zostavax

June 21

GLP-1 analogue reduces cardiovascular risk in diabetes patients
Commissioner Gottlieb gets tough on schemes to thwart competition
Changes aim to make it easier for small and rural providers to participate
Designated sepsis nurses and coordinators make a difference
Amphetamine-containing product consists of drug-releasing beads

June 20

Lawmakers to start reviewing bill in the next few days
Chronic diseases claim millions of lives and cost trillions of dollars, report finds
Fluoroquinolone is active against MRSA

June 19

GOP leaders pursue moderate votes
Industry influences working group’s deliberations, report contends
Novel “post-market approach” expected this fall
Botulinum toxin product carries boxed warning

Pages